Novelix promoters increase stake via warrant conversion

1 min read     Updated on 15 Jul 2026, 10:44 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Novelix Pharmaceuticals disclosed on July 13, 2026, that its promoters increased their shareholding through the conversion of warrants into equity shares on July 9, 2026. The allotment was executed via a preferential offer basis under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Following the transaction, the total voting capital stands at 28,470,000 equity shares, with Srinidhi Fine Chemicals LLP, Nanhari Belide, Vupparapalli Chandrasekhar Reddy, and Neha Gattu acquiring shares valued at ₹4,20,00,000, ₹8,00,00,000, ₹15,50,00,000, and ₹2,00,00,000 respectively.

powered bylight_fuzz_icon
45474718

*this image is generated using AI for illustrative purposes only.

Novelix Pharmaceuticals disclosed on July 13, 2026, that its promoters and promoter group increased their shareholding through the conversion of warrants into equity shares. The allotment, which occurred on July 9, 2026, was executed via a preferential offer basis as required under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This adjustment significantly alters the capital structure and promoter stakes within the company.

The total voting capital of Novelix Pharmaceuticals stands at 28,470,000 equity shares following the transaction. The conversion involved multiple acquirers, including Srinidhi Fine Chemicals LLP, Nanhari Belide, Vupparapalli Chandrasekhar Reddy, and Neha Gattu. The disclosures were submitted to BSE Limited by Venkateshwarlu Pulluri, Whole-time Director, on behalf of the company.

Shareholding Changes

The table below details the specific changes in holdings for the key acquirers, reflecting the movement from pre-allotment to post-allotment positions.

Acquirer Holding Before Acquisition % Before Acquisition Holding After Acquisition % After Acquisition
Srinidhi Fine Chemicals LLP 7,902,000 33.07 % 10,002,000 35.13 %
Vupparapalli Chandrasekhar Reddy 2,130,733 8.92 % 2,905,733 10.21 %
Nanhari Belide 800,000 3.35 % 1,200,000 4.21 %
Neha Gattu 0 0.00 % 100,000 0.35 %

Srinidhi Fine Chemicals LLP acquired 2,100,000 shares at a value of ₹4,20,00,000, while Vupparapalli Chandrasekhar Reddy acquired 775,000 shares valued at ₹15,50,00,000. Nanhari Belide added 400,000 shares worth ₹8,00,00,000, and Neha Gattu acquired 100,000 shares valued at ₹2,00,00,000. The company confirmed that no trading in derivatives was conducted by these individuals during this period.

Historical Stock Returns for Trimurthi

1 Day5 Days1 Month6 Months1 Year5 Years
-3.46%-1.06%-11.38%+16.85%+64.17%+725.36%

How will the increased promoter holding influence Novelix Pharmaceuticals' strategic decision-making and future capital allocation?

What are the potential market reactions to the dilution of public shareholding and the consolidation of promoter stakes?

Could this move signal upcoming expansion plans or acquisitions by the company given the fresh infusion of equity capital?

Novelix Pharmaceuticals EGM approves preferential share issue

1 min read     Updated on 02 Jul 2026, 08:41 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Novelix Pharmaceuticals Limited conducted an Extraordinary General Meeting (EGM) on July 1, 2026, via video conferencing to approve the issuance of equity shares on a preferential basis. The special resolution was passed with 99.9999% of votes in favour. The meeting included remote e-voting facilities facilitated by CDSL and scrutinized by Mr. Bharat Khaniwal.

powered bylight_fuzz_icon
44459543

*this image is generated using AI for illustrative purposes only.

Novelix Pharmaceuticals Limited held an Extraordinary General Meeting (EGM) on July 1, 2026, to approve the issuance of equity shares on a preferential basis. The special resolution was passed with 99.9999% of votes in favour, authorizing the company to raise capital through this mechanism. The meeting was conducted via video conferencing and chaired by Director Mr. Gnana Prakash Gattu.

The proceedings commenced at 3:30 PM and concluded at 3:54 PM. Mr. Venkateshwarlu Pulluru, Whole-time Director, and other board members were present. The meeting satisfied the requisite quorum, and the notice was taken as read after being circulated via prescribed modes.

E-Voting and Scrutiny

Pursuant to the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company provided a remote e-voting facility. This facility was available from 9:00 AM on June 28, 2026, until 5:00 PM on June 30, 2026. Additionally, members could vote via e-voting for 15 minutes during the meeting if they had not cast their votes remotely.

The Board engaged Central Depository Services (India) Limited (CDSL) to facilitate the remote e-voting process. Mr. Bharat Khaniwal, a Practicing Company Secretary from Jaipur, was appointed as the Scrutinizer to oversee the voting process.

Business Transacted

The primary agenda item was the special resolution regarding the issue of equity shares on a preferential basis. The resolution was passed with 99.9999% of votes in favour. The details of the resolution are as follows:

Sl. No. Details of the Agenda Resolution Mode of Voting
1 Item No. 1: Issue of Equity Shares on Preferential basis Special Resolution E-Voting

The Chairman informed members that the combined results of the remote e-voting and the e-voting conducted during the EGM would be announced within 48 hours of the meeting's conclusion. These results will be intimated to the stock exchanges and displayed on the company's website.

The meeting concluded with a vote of thanks after all business was transacted. The outcome of the voting will be communicated separately to the stock exchanges.

Historical Stock Returns for Trimurthi

1 Day5 Days1 Month6 Months1 Year5 Years
-3.46%-1.06%-11.38%+16.85%+64.17%+725.36%

What specific strategic initiatives will the capital raised from the preferential allotment fund?

Who are the likely institutional investors or strategic partners being targeted for this preferential issue?

How will the issuance of new equity shares impact the existing shareholders' earnings per share (EPS) and ownership structure?

More News on Trimurthi

1 Year Returns:+64.17%